Sension M, Osterman M, Brunet L, Mills A, Mounzer K, Fusco J, Fusco G. Assessing the potential for drug-drug interaction with long-acting pre-exposure prophylaxis in the OPERA Cohort. In: ACTHIV. Chicago, IL, USA; May 1-3, 2025.
Research Category: Abstracts and Posters
Characteristics of treatment interruptions and virologic outcomes of individuals prescribed B/F/TAF after an antiretroviral treatment interruption: Findings from the OPERA Cohort
Mounzer K, Osterman MD, Brunet L, Hsu RK, Pierone GJ, Fusco JS, Prata Menezes N, Gruber J, Lim T, Dunbar M, Fusco GP. Characteristics of treatment interruptions and virologic outcomes of individuals prescribed B/F/TAF after an antiretroviral treatment interruption: Findings from the OPERA Cohort. In: ACTHIV. Chicago, IL, USA; May 1-3, 2025.
Risk of Incident Hypertension with Common Antiretroviral Agent Combinations in the OPERA Cohort [Poster 823]
Lackey PC, Brunet L, Fusco J, Pierone Jr G, Wohlfeiler MB, Dieterich D, Henegar C, Vannappagari V, Jones B, de Ruiter A, Fusco G. Risk of Incident Hypertension with Common Antiretroviral Agent Combinations in the OPERA Cohort [Poster 823]. Conference on Retroviruses and Opportunistic Infections (CROI). San Francisco, CA, USA; March 9-12, 2025
Long-term CAB+RPV LA Effectiveness in Virologically Suppressed Individuals in the OPERA Cohort [Poster 674]
Sension M, Hsu RK, Fusco JS, Levis B, Brunet L, Cochran Q, Sridhar G, Vannappagari V, van Wyk J, Wohlfeiler M, Fusco GP. Long-term CAB+RPV LA Effectiveness in Virologically Suppressed Individuals in the OPERA Cohort [Poster 674]. Conference on Retroviruses and Opportunistic Infections (CROI). San Francisco, CA, USA; March 9-12, 2025
P-038 Moving More People with a Hepatitis C Diagnosis to Treatment: Alerts in CHORUS, a Clinical Decision Support System
Dieterich DT, Weber RP, Hsu RK, Millner C, Levis B, Fusco JS, Brunet L, Son A, Kreter B, Fusco GP. P-038 Moving More People with a Hepatitis C Diagnosis to Treatment: Alerts in CHORUS, a Clinical Decision Support System. Global Hepatitis Summit. Los Angeles, CA, USA; March 18-21, 2025
Clinical Outcomes Among Virologically Suppressed Women Receiving CAB+RPV LA in the OPERA Cohort [Poster 676]
Altamirano J, Levis B, Markarian C, Cochran Q, Sherman C, Toeque M-G, Armas L, Sridhar G, Vannappagari V, Brown K, Fusco JS. Clinical Outcomes Among Virologically Suppressed Women Receiving CAB+RPV LA in the OPERA Cohort [Poster 676]. Conference on Retroviruses and Opportunistic Infections (CROI). San Francisco, CA, USA; March 9-12, 2025
First Year of Lenacapavir Long-Acting Injectable Use in the OPERA Cohort [Poster 688]
Mounzer K, Brunet L, Hsu R, Lackey PC, Sension M, Wohlfeiler MB, Gruber J, Dunbar MS, Park S, Fusco J, Fusco G. First Year of Lenacapavir Long-Acting Injectable Use in the OPERA Cohort [Poster 688]. Conference on Retroviruses and Opportunistic Infections (CROI). San Francisco, CA, USA; March 9-12, 2025
Reducing Duplicative Data Entry Increased Available Time for Patient Care and Reduced Labor Costs [Poster 25776]
Sullivan A, Fernandez P, Supler M, Fusco A. Reducing Duplicative Data Entry Increased Available Time for Patient Care and Reduced Labor Costs [Poster 25776]. National Ryan White Conference on HIV Care & Treatment. Washington, DC, USA; 2024
Improved Testing for Chronic Disease Among Long-Acting Injectable Versus Daily Oral Antiretroviral Therapy Users in the OPERA Cohort
Lackey P, Palmieri Weber R, Pierone Jr G, Sension M, Mills A, Wohlfeiler M, Fusco J, Levis B, Sridhar G, Vannappagari V, van Wyk J, Fusco G. Improved Testing for Chronic Disease Among Long-Acting Injectable Versus Daily Oral Antiretroviral Therapy Users in the OPERA Cohort. IDWeek. Los Angeles, CA, USA; October 16-19, 2024
PrEP Decision Factors: A CHORUS Healthcare Professional Survey
Hsu R, Frost KR, Levis B, Palmieri Weber R, Millner C, Barnett S, Sherman C, Markarian C, Fusco JS, Osterman MD, Sarkar S, Vannappagari V, van Wyk J, Fusco GP. PrEP Decision Factors: A CHORUS Healthcare Professional Survey. IDWeek. Los Angeles, CA, USA; October 16-19, 2024